ask="1.60"
ask_size="4000"
average_daily_volume="923935"
bid="1.35"
bid_size="1500"
book_value="1.06"
change="+0.10"
change_from_200_day_moving_average="-1.09"
change_from_50_day_moving_average="0.00"
change_from_52_week_high="-7.55"
change_From_52_week_low="0.41"
change_in_percent="+8.00%"
close="1.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.55"
ebitda="-79.23M"
eps_estimate_current_year="-1.34"
eps_estimate_next_quarter="-0.35"
eps_estimate_next_year="-1.07"
ex_dividend_date="N/A"
float_shares="36689000"
high="1.45"
high_52_weeks="8.90"
last_trade_date="3/13/2017"
last_trade_price="1.35"
last_trade_size="66976"
last_trade_time="4:00pm"
low="1.20"
low_52_weeks="0.94"
market_capitalization="71.46M"
moving_average_200_day="2.44"
moving_average_50_day="1.35"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="22.67"
open="1.20"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-44.76%"
percent_change_from_50_day_moving_average="+0.15%"
percent_change_from_52_week_high="-84.83%"
percent_change_from_52_week_low="+43.62%"
previous_close="1.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.18"
price_per_sales="55.41"
revenue="1.19M"
shares_outstanding="52932000"
short_ratio="3.47"
stock_exchange="NGM"
symbol="RGLS"
volume="1919011"
weeks_range_52="0.94 - 8.90"
